Katelyn R. Sheneman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Katelyn R. Sheneman has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Joshua L. Hood
Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, USA
2 shared publications - Matthew B. Lawrenz
Department of Microbiology and Immunology, University of Louisville School of Medicine
2 shared publications - Michael L. Merchant
Department of Medicine, University of Louisville, Louisville, Kentucky
2 shared publications - Silvia M. Uriarte
University of Louisville
2 shared publications - Timothy D. Cummins
Division of Nephrology and Hypertension, Department of Medicine, University of Louisville, Louisville, Kentucky
2 shared publications - Daniel Erickson
Department of Microbiology & Immunology, University of Louisville
1 shared publication
Latest Publications
- Open Access
- 14 October 2025
- Published by Taylor & Francis in Gut Microbes
- Vol. 17 (1) , 2566302
A sucrose-rich diet promotes Clostridioides difficile carriage without prior antibiotics and significantly exacerbates both acute disease and long-term colonization
Clostridioides difficile is a major cause of healthcare-associated diarrhea, with rising rates of community-acquired infections and asymptomatic carriage. While antibiotic exposure is a well-established risk factor, the role of diet in modulating susceptibility remains underexplored. Here, we demonstrate that a high-sucrose diet profoundly alters host susceptibility to C. difficile in a murine model. Mice consuming sucrose-rich chow exhibited exacerbated disease severity, characterized by increased weight loss, elevated clinical scores, heightened toxin burden, and persistent intestinal inflammation. Mice fed a high-sucrose diet failed to clear C. difficile and remained colonized long-term remaining susceptible to recurrent disease. Critically, high-sucrose-diet mice were susceptible to asymptomatic C. difficile carriage without prior antibiotic treatment, which progressed to overt CDI upon antibiotic exposure. Microbiome and metabolome profiling revealed that consumption of a sucrose-rich diet reshaped the gut microbiota, marked by blooms of Enterococcus and Akkermansia, a reduction in beneficial taxa, and remodeled the metabolome to favor C. difficile germination and growth. These findings establish dietary sucrose as a modulator of colonization resistance and identify a novel model of diet-induced asymptomatic carriage, with implications for the rising burden of community-associated C. difficile infection.
- 14 October 2025
- Published by Taylor & Francis in Gut Microbes
- Vol. 17 (1) , 2566302
Open AccessA sucrose-rich diet promotes Clostridioides difficile carriage without prior antibiotics and significantly exacerbates both acute disease and long-term colonization
Clostridioides difficile is a major cause of healthcare-associated diarrhea, with rising rates of community-acquired infections and asymptomatic carriage. While antibiotic exposure is a well-established risk factor, the role of diet in modulating susceptibility remains underexplored. Here, we demonstrate that a high-sucrose diet profoundly alters host susceptibility to C. difficile in a murine model. Mice consuming sucrose-rich chow exhibited exacerbated disease severity, characterized by increased weight loss, elevated clinical scores, heightened toxin burden, and persistent intestinal inflammation. Mice fed a high-sucrose diet failed to clear C. difficile and remained colonized long-term remaining susceptible to recurrent disease. Critically, high-sucrose-diet mice were susceptible to asymptomatic C. difficile carriage without prior antibiotic treatment, which progressed to overt CDI upon antibiotic exposure. Microbiome and metabolome profiling revealed that consumption of a sucrose-rich diet reshaped the gut microbiota, marked by blooms of Enterococcus and Akkermansia, a reduction in beneficial taxa, and remodeled the metabolome to favor C. difficile germination and growth. These findings establish dietary sucrose as a modulator of colonization resistance and identify a novel model of diet-induced asymptomatic carriage, with implications for the rising burden of community-associated C. difficile infection.
- Open Access
- 16 April 2025
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 14 (4) , e70074
Yersinia pestis Actively Inhibits the Production of Extracellular Vesicles by Human Neutrophils
Yersinia pestis is the etiologic agent of the plague. A hallmark of plague is subversion of the host immune response by disrupting host signalling pathways required for inflammation. This non‐inflammatory environment permits bacterial colonization and has been shown to be essential for disease manifestation. Previous work has shown that Y. pestis inhibits phagocytosis and degranulation by neutrophils. Manipulation of these key vesicular trafficking pathways suggests that Y. pestis influences extracellular vesicle (EV) secretion, cargo selection, trafficking and/or maturation. Our goals were to define the EV population produced by neutrophils in response to Y. pestis and determine how these vesicles might influence inflammation. Towards these goals, EVs were isolated from human neutrophils infected with Y. pestis or a mutant lacking bacterial effector proteins known to manipulate host cell signalling. Mass spectrometry data revealed that cargoes packaged in EVs isolated from mutant infected cells were enriched with antimicrobial and cytotoxic proteins, contents which differed from uninfected and Y. pestis infected cells. Further, EVs produced in response to Y. pestis lacked inflammatory properties observed in those isolated from neutrophils responding to the mutant. Together, these data demonstrate that Y. pestis actively inhibits the production of antimicrobial EVs produced by neutrophils, likely contributing to immune evasion.
- 16 April 2025
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 14 (4) , e70074
Open AccessYersinia pestis Actively Inhibits the Production of Extracellular Vesicles by Human Neutrophils
Yersinia pestis is the etiologic agent of the plague. A hallmark of plague is subversion of the host immune response by disrupting host signalling pathways required for inflammation. This non‐inflammatory environment permits bacterial colonization and has been shown to be essential for disease manifestation. Previous work has shown that Y. pestis inhibits phagocytosis and degranulation by neutrophils. Manipulation of these key vesicular trafficking pathways suggests that Y. pestis influences extracellular vesicle (EV) secretion, cargo selection, trafficking and/or maturation. Our goals were to define the EV population produced by neutrophils in response to Y. pestis and determine how these vesicles might influence inflammation. Towards these goals, EVs were isolated from human neutrophils infected with Y. pestis or a mutant lacking bacterial effector proteins known to manipulate host cell signalling. Mass spectrometry data revealed that cargoes packaged in EVs isolated from mutant infected cells were enriched with antimicrobial and cytotoxic proteins, contents which differed from uninfected and Y. pestis infected cells. Further, EVs produced in response to Y. pestis lacked inflammatory properties observed in those isolated from neutrophils responding to the mutant. Together, these data demonstrate that Y. pestis actively inhibits the production of antimicrobial EVs produced by neutrophils, likely contributing to immune evasion.
- Open Access
Yersinia pestis actively inhibits the production of extracellular vesicles by human neutrophils
Yersinia pestis is the etiologic agent of the plague. A hallmark of plague is subversion of the host immune response by disrupting host signaling pathways required for inflammation. This non-inflammatory environment permits bacterial colonization and has been shown to be essential for disease manifestation. Previous work has shown that Y. pestis inhibits phagocytosis and degranulation by neutrophils. Manipulation of these key vesicular trafficking pathways suggests that Y. pestis influences EV secretion, cargo selection, trafficking, and/or maturation. Our goal was to define the EV population produced by neutrophils in response to Y. pestis and determine how these vesicles might influence inflammation. Toward these goals, EVs were isolated from human neutrophils infected with Y. pestis or a mutant lacking bacterial effector proteins known to manipulate host cell signaling. Mass spectrometry data revealed that cargoes packaged in EVs isolated from mutant infected cells were enriched with antimicrobials and cytotoxic proteins, contents which differed from uninfected and Y. pestis infected cells. Further, EVs produced in response to Y. pestis lacked inflammatory properties observed in those isolated from neutrophils responding to the mutant. Together, these data demonstrate that Y. pestis actively inhibits the production of antimicrobial EVs produced by neutrophils, likely contributing to immune evasion.
Open AccessYersinia pestis actively inhibits the production of extracellular vesicles by human neutrophils
Yersinia pestis is the etiologic agent of the plague. A hallmark of plague is subversion of the host immune response by disrupting host signaling pathways required for inflammation. This non-inflammatory environment permits bacterial colonization and has been shown to be essential for disease manifestation. Previous work has shown that Y. pestis inhibits phagocytosis and degranulation by neutrophils. Manipulation of these key vesicular trafficking pathways suggests that Y. pestis influences EV secretion, cargo selection, trafficking, and/or maturation. Our goal was to define the EV population produced by neutrophils in response to Y. pestis and determine how these vesicles might influence inflammation. Toward these goals, EVs were isolated from human neutrophils infected with Y. pestis or a mutant lacking bacterial effector proteins known to manipulate host cell signaling. Mass spectrometry data revealed that cargoes packaged in EVs isolated from mutant infected cells were enriched with antimicrobials and cytotoxic proteins, contents which differed from uninfected and Y. pestis infected cells. Further, EVs produced in response to Y. pestis lacked inflammatory properties observed in those isolated from neutrophils responding to the mutant. Together, these data demonstrate that Y. pestis actively inhibits the production of antimicrobial EVs produced by neutrophils, likely contributing to immune evasion.